2. Pneumonia
• acute infection of the
pulmonary parenchyma
• inflammation of the lung
parenchyma
• is the leading cause of
death globally - children
<5 yr. (From World Health Organization and Maternal
and Child Epidemiology Estimation Group
estimates, 2015.)
3. Causes
• mostly caused by microorganisms
• Bacterial and Viral
Infectious
• Aspiration of food, gastric acid, foreign
bodies, hydrocarbons & lipoid substances
• Hypersensitivity reaction
• Drug or radiation-induced pneumonitis
Non infectious
4. Infectious
• Bacterial
- Streptococcus pneumoniae (pneumococcus) - children 3 weeks to 4 yr
of age.
- Mycoplasma pneumoniae and Chlamydophila pneumoniae - children
age 5 yr and older.
• Viral pathogens are the most common causes of LRTI in infants and
children older than 1 month but younger than 5 yr of age.
5. Pneumonia Etiologies Grouped by Age of the
Patient
AGE GROUP FREQUENT PATHOGENS (IN ORDER OF FREQUENCY)
Neonates
(<3 wk)
Group B streptococcus, Escherichia coli, other Gram-negative
bacilli, Streptococcus pneumoniae, Haemophilus influenzae (type
b,* nontypeable)
3 wk - 3 mo Respiratory syncytial virus, other respiratory viruses (rhinoviruses,
parainfluenza viruses, influenza viruses, human
metapneumovirus, adenovirus), S. pneumoniae, H. influenzae
(type b,* nontypeable); Chlamydia trachomatis
Adapted from Kliegman RM, Marcdante KJ, Jenson HJ, et al: Nelson essentials of pediatrics , ed 5, Philadelphia, 2006, Elsevier, p. 507.
6. Pneumonia Etiologies Grouped by Age of the
Patient
4 mo - 4 yr Respiratory syncytial virus, other respiratory viruses (rhinoviruses,
parainfluenza viruses, influenza viruses, human metapneumovirus,
adenovirus), S. pneumoniae, H. influenzae (type b,* nontypeable),
Mycoplasma pneumoniae, group A streptococcus
≥5 yr M. pneumoniae, S. pneumoniae, Chlamydophila pneumoniae, H.
influenzae (type b,* nontypeable), influenza viruses, adenovirus,
other respiratory viruses, Legionella pneumophila
Adapted from Kliegman RM, Marcdante KJ, Jenson HJ, et al: Nelson essentials of pediatrics , ed 5, Philadelphia, 2006, Elsevier, p. 507.
7. Defense Mechanism of Lower Respiratory Tract Process against Infection
Mucociliary Clearance
Macrophages
Secretory Immunoglobulin A
Clearing of the Airways by Coughing
8. Pathogenesis
Bacteria enter
the lungs (from
nose, airborne
droplets or
blood)
Bacteria may
invade spaces
between cells
and alveoli
Macrophages
and neutrophils
inactivate the
bacteria.
Neutrophils also
release cytokines
When
macrophages are
overwhelmed
General
activation of
immune system.
Inflammatory Response
(Increases local microvascular permeability)
9. Inflammatory Response
(Increase Microvascular Permeability)
Movement of fluid , WBC, Proteins in
alveolar space
Production of a fibrin rich exudates
that fills infected and neighboring
alveoli spaces alveoli airless
Reduced gas exchange –organs
oxygen deprived
Cytokines ad Chemokines (TNF, IL-1,
IL – 6) , spill in the systemic
circulation systemic Inflammatory
response
- Activates production of WBC by
bone Marrow
- Increases cardiac output
- Elevates Body Temperature
- Responsible for sickness behavior:
Fatigue, anorexia, coldness
Tachypnea and Tachycardia
IL-1 , TNF -
increases
cyclooxygenase
converts AA to
Prostaglandin
Resets temperature
to a higher level –
elevated
Temperature
11. Infants
• Upper respiratory tract infection
• Poor feeding and appear ill
• respiratory distress manifested as:
- grunting
- nasal flaring
- retractions (supraclavicular, intercostal, and subcostal areas)
- tachypnea
- tachycardia
- air hunger; and
- often cyanosis
12. PHYSICAL FINDINGS BASED ON STAGE OF PNEUMONIA
Early in course of illness - Diminished breath sounds
- Scattered crackles
- Ronchi over affected lung field
Upon development of
increasing
consolidation or
complications
- Dullness on percussion
- Diminished breath sounds
- Chest lag on affected side
- Abdominal pain (common in lower lobe pneumonia)
- Abdominal distention (d/t gastric dilation from
swallowed air or ileus)
- Liver may seem enlarged (d/t downward displacement
of diaphragm secondary to hyperinflation of lungs or
superimposed CHF)
13. VIRAL PNEUMONIA BACTERIAL PNEUMONIA
Description Results from spread of infection along
airways accompanied by direct injury of
respiratory epithelium
Organisms colonize the trachea and subsequently
gain access to the lungs / direct seeding of lung
tissue after bacteremia
Fever Low fever (Begins) High Fever
Signs and
Symptoms
Wheezes are more common in viral than
bacterial
Adults & Older children :
- Drowsiness w/ intermittent periods of
restlessness,
Rapid respirations ,- Anxiety and delirium
Peripheral white
blood cell (WBC)
count
Normal or elevated but is usually not
higher than 20,000/mm3,
Range of 15,000 - 40,000/mm3
Associated
Symptoms
Gastrointestinal disturbances : vomiting, anorexia,
diarrhea, and abdominal distention
Definitive Tests Rests on the isolation of a virus or
detection of the viral genome or antigen in
respiratory tract secretions.
Requires isolation of an organism from the blood,
pleural fluid, or lung.
14. References:
• Dantzer, R. (2006). Cytokine, Sickness Behavior, and Depression. Neurologic Clinics, 24(3), 441–460. doi:
10.1016/j.ncl.2006.03.003
• Kumar, V., Abbas, A. K., & Aster, J. C. (2015). Robbins and Cotran pathologic basis of disease. Philadelphia: Elsevier-
Saunders.
• Elsevier Health Sciences. (2018). Harriet Lane Handbook. Saint Louis.
15.
16.
17. Pathogenesis: Viral Pneumonia
Spread of infection along airways accompanied by
direct
injury of respiratory epithelium
Airway obstruction d/t:
Swelling, abnormal secretions & cellular debris
Significant hypoxemia d/t:
Atelectasis, interstitial edema, V/Q mismatch
18. M. Pneumoniae
Colonization of trachea or direct seeding
after bacteremia attaches to
respiratory epithelium
Inhibits ciliary action
Cellular destruction
Progression of infection
Airway obstruction d/t sloughed cellular
debris, inflammatory cells, & mucus
S. Pneumoniae Infection
Produces local edema
Aids in proliferation of organisms & spread into
adjacent portion of lung
Characteristic focal lobar involvement
19. Group A Streptococcus
LRTI
• necrosis of tracheobronchial
mucosa
• formation of large amounts of
exudate, edema, and local
hemorrhage, with extension into
the interalveolar septa
• involvement of lymphatic vessels
• Increased likelihood pleural
involvement
S. Aureus Pneumonia
Extensive areas of hemorrhagic
necrosis & irregular areas of
cavitation of lung parenchyma
Pneumatoceles, empyema,
bronchopulmonary fistulas
Editor's Notes
Pneumonia is the leading infectious killer of children worldwide, as shown by this illustration of global distribution of cause-specific infectious mortality among children younger than age 5 yr in 2015. Pneumonia causes one-third of all under-5 deaths from infection. (From World Health Organization and Maternal and Child Epidemiology Estimation Group estimates, 2015.)
Pneumonia mortality is closely linked to poverty. More than 99% of pneumonia deaths are in low- and middle-income countries, with the highest pneumonia mortality rate occurring in poorly developed countries in Africa and South Asia
Most cases of pneumonia are caused by microorganisms. The cause of pneumonia in an individual patient is often difficult to determine because direct culture of lung tissue is invasive and rarely performed.
Cultures performed on specimens in children obtained from the upper respiratory tract or sputum typically do not accurately reflect the cause of
lower respiratory tract infection.
Hypersensitivity pneumonitis (extrinsic allergic pneumonitis) “agricultural dust” is a disease of the lungs in which your lungs become inflamed as an allergic reaction to inhaled dust, fungus, molds or chemicals. Exogenous lipoid pneumonia (ELP) is a rare form of pneumonia caused by inhalation or aspiration of a fatty substance. ELP has been reported with inhalation or ingestion of petroleum jelly, mineral oils, “nasal drops,” and even intravenous injection of olive oil.
Drug induced pneumonitis – adverse drug reaction due to antineoplastic agents are a common for of iatrogenic injury and the lungs are frequent target
It is probable that this decline results from the introduction of antibiotics, vaccines, and the expansion of medical insurance coverage for children.
Improved access to healthcare in rural areas of developing countries and the introduction of pneumococcal conjugate vaccines (see Chapter 182) were also important contributors to the further reductions in pneumonia-related deaths.
Viral pathogens are the most common causes of lower respiratory tract infections in infants and children older than 1 mo but younger than 5 yr of age. Viruses can be detected in 40-80% of children with pneumonia using molecular diagnostic methods
The age of the patients can likely suggest the pathogens
H. influenzae or S. pneumoniae has been significantly reduced in areas where routine immunization has been implemented.
Of the respiratory viruses, respiratory syncytial virus (RSV) and rhinoviruses are the most commonly identified pathogens, especially in children younger than 2 yr of age. RSV is particularly severe among infants and young children.
Immunization status is relevant because children fully immunized against H. influenzae type b and S. pneumoniae are less likely to be infected with these pathogens. Children who are immunosuppressed or who have an underlying illness may be at risk for specific pathogens, such as Pseudomonas spp. in patients with cystic fibrosis.
Lungs are essential organs for respiration. Their cardinal function is , the exchange of gases between inspired air and blood. The lower respiratory tract is normally kept sterile by physiologic defense mechanisms, including mucocilliary clearance, the properties of normal secretions such as secretory immunoglobulin (Ig) A, and clearing of the airway by coughing.
Immunologic defense mechanisms of the lung that limit invasion by pathogenic organisms include macrophages that are present in alveoli and bronchioles, secretory IgA, and other immunoglobulins.
Trauma, anesthesia, and aspiration increase the risk of pulmonary infection.
Cilia, tiny muscular, hair-like projections on the cells that line the airway, are one of the respiratory system's defense mechanisms. Cilia propel a liquid layer of mucus that covers the airways. The mucus layer traps pathogens (potentially infectious microorganisms) and other particles, preventing them from reaching the lungs. Pathogens and particles that are trapped on the mucus layer are coughed out or moved to the mouth and swallowed.
IgA – (comes from vascular compartment thru diffusion and made up by plasma cells in the lung tissue), most abundant immunoglobulin in the upper respiratory tract, serves as an immunologic barrier, inhibiting binding of microorganism to the mucosal surface and bacterial growth,.
Most often occurs when respiratory tract organisms colonize the trachea and subsequently gain access to the lungs but pneumonia may also result from direct seeding of lung tissue after bacteremia.
Pneumonia is frequently preceded by several days of symptoms of an upper respiratory tract infection, typically rhinitis and cough.
Fever – low grade in viral than bacterial
Tachypnea - most consistent clinical manifestation of pneumonia
Increased work of breathing accompanied by intercostal, subcostal, and suprasternal retractions, nasal flaring, and use of accessory muscles is common.
Severe infection may be accompanied by cyanosis and lethargy, especially in infants.
Auscultation of the chest may reveal crackles and wheezing
Respiratory distress means results when breathing does not match the body’s metabolic demand for oxygen due to failure of oxygenation and or ventilation. While respiratory failure is a syndrome which the respiratory system fails in one or both of its gas exchange functions: oxygenation and carbon dioxide elimination.
According to Bates , In infants, abnormal work of breathing combined with abnormal findings on auscultation is the best finding for ruling in pneumonia.
Group A streptococcus lower respiratory tract infection typically results in more diffuse lung involvement with interstitial pneumonia.